CHARLES RIVER LABORATORIES INTERNATIONAL INC
For the period ended Dec 30, 2023. Filed Feb 14, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 14, 2024
CRL$353.34+4.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Equity for fiscal years
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
| Common stock · Additional Paid-In Capital · Retained Earnings · Accumulated Other Comprehensive Income (Loss) · Treasury Stock · Total EquityAttributableto CommonShareholders · NoncontrollingInterest · TotalEquity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount | |||||||||||
| December 26, 2020 | 49,767 | $498 | $1,627,564 | $625,414 | $(138,874) | — | $— | $2,114,602 | $3,567 | $2,118,169 | |
| Net income | — | — | — | 390,982 | — | — | — | 390,982 | 2,480 | 393,462 | |
| Other comprehensive (loss) | — | — | — | — | (25,866) | — | — | (25,866) | — | (25,866) | |
| Dividends declared to noncontrolling interest | — | — | — | — | — | — | — | — | (1,885) | (1,885) | |
| Adjustment to noncontrolling interest fair value | — | — | (21,312) | — | — | — | — | (21,312) | — | (21,312) | |
| Issuance of stock under employee compensation plans | 861 | 8 | 45,639 | — | — | — | — | 45,647 | — | 45,647 | |
| Purchase of treasury shares | — | — | — | — | — | 148 | (40,707) | (40,707) | — | (40,707) | |
| Retirement of treasury shares | (148) | (1) | (5,061) | (35,645) | — | (148) | 40,707 | — | — | — | |
| Stock-based compensation | — | — | 71,474 | — | — | — | — | 71,474 | — | 71,474 | |
| December 25, 2021 | 50,480 | 505 | 1,718,304 | 980,751 | (164,740) | — | — | 2,534,820 | 4,162 | 2,538,982 | |
| Net income | — | — | — | 486,226 | — | — | — | 486,226 | 2,362 | 488,588 | |
| Other comprehensive (loss) | — | — | — | — | (97,317) | — | — | (97,317) | — | (97,317) | |
| Dividends declared to noncontrolling interest | — | — | — | — | — | — | — | — | (1,739) | (1,739) | |
| Adjustment of redeemable noncontrolling interest to redemption value | — | — | (7,507) | — | — | — | — | (7,507) | — | (7,507) | |
| Issuance of stock under employee compensation plans | 594 | 5 | 25,100 | — | — | — | — | 25,105 | — | 25,105 | |
| Purchase of treasury shares | — | — | — | — | — | 130 | (38,651) | (38,651) | — | (38,651) | |
| Retirement of treasury shares | (130) | (1) | (4,574) | (34,076) | — | (130) | 38,651 | — | — | — | |
| Stock-based compensation | 73,617 | 73,617 | — | 73,617 | |||||||
| December 31, 2022 | 50,944 | 509 | 1,804,940 | 1,432,901 | (262,057) | — | — | 2,976,293 | 4,785 | 2,981,078 | |
| Net income | — | — | — | 474,624 | — | — | — | 474,624 | 2,254 | 476,878 | |
| Other comprehensive income | — | — | — | — | 65,630 | — | — | 65,630 | — | 65,630 | |
| Dividends declared to noncontrolling interest | — | — | — | — | — | — | — | — | (1,645) | (1,645) | |
| Adjustment of redeemable noncontrolling interest to redemption value | — | — | 5,694 | — | — | — | — | 5,694 | — | 5,694 | |
| Gain on purchase of remaining equity interest of Vital River redeemable noncontrolling interest | — | — | 1,151 | — | — | — | — | 1,151 | — | 1,151 | |
| Issuance of stock under employee compensation plans | 499 | 5 | 25,592 | — | — | — | — | 25,597 | — | 25,597 | |
| Purchase of treasury shares | — | — | — | — | — | 105 | (24,155) | (24,155) | — | (24,155) | |
| Retirement of treasury shares | (105) | (1) | (3,847) | (20,307) | — | (105) | 24,155 | — | — | — | |
| Stock-based compensation | 72,048 | 72,048 | — | 72,048 | |||||||
| December 30, 2023 | 51,338 | $513 | $1,905,578 | $1,887,218 | $(196,427) | — | $— | $3,596,882 | $5,394 | $3,602,276 | |
| See Notes to Consolidated Financial Statements. | |||||||||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.